Treatments with tamoxifen and an antiestradiol antibody have beneficial effects on experimental SLE via cytokine modulation

Annals of the New York Academy of Sciences

Volumn 815, Issue , 1997, Pages 367-368

  Sthoeger, Z ^a   Dayan, M ^a   Zinger, H ^a   Kalush, F ^a   Mor, G ^a   Amir Zaltman, Y ^a   Kohen, F ^a   Mozes, E ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; AUTOANTIBODY; CYTOKINE; ESTROGEN; MONOCLONAL ANTIBODY; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALIA;

EID: 0030877511     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52086.x     Document Type: Conference Paper

References (4)

1. LAHITA, R. G. 1985. Sex steroids and the rheumatic diseases. Arthritis Rheum. 28: 126.
2. STHOEGER, Z. M., Z. BENTWICH, H. ZINGER & E. MOZES. 1994. The beneficial effect of the estrogen antagonist tamoxifen on experimental SLE. J. Rheumatol. 21: 2231-2238.
3. MENDELOVIC, S., S. BROCKE, Y. SHOENFELD, M. BEN-BASSAT, A. MESHORER, R. BAKIMER & E. MOZES. 1988. Induction of SLE-like disease by a common human anti-DNA idiotype. Proc. Natl. Acad. Sci. U.S.A. 85: 2260-2264.
4. MOZES, E., F. KALUSH & B. TARTAKOVSKY. 1990. The physiological and pathological effects of cytokines. In Progress in Leukocyte Biology, p. 111-116. Wiley-Liss. New York.